Cradle

Delft, Netherlands Founded: 2021 • Age: 5 yrs
Chemoproteomics solutions are provided for protein design and development.
Request Access

About Cradle

Cradle is a company based in Delft (Netherlands) founded in 2021 by Stef Van Grieken and Jelle Prins. It operates as a SaaS (Software-as-a-Service), and Subscription Services. Cradle has raised $102.71 million across 3 funding rounds from investors including IVP, Index Ventures and Kindred. Cradle offers products and services including Cradle AI Platform. Cradle operates in a competitive market with competitors including Nimbus Therapeutics, EvolutionaryScale, Evozyne, Profluent Bio and Frontier Medicines, among others.

  • Headquarter Delft, Netherlands
  • Founders Stef Van Grieken, Jelle Prins
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $102.71 M (USD)

    in 3 rounds

  • Latest Funding Round
    $73 M (USD), Series B

    Nov 26, 2024

  • Investors
    IVP

    & 6 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cradle

Cradle offers a comprehensive portfolio of products and services, including Cradle AI Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI platform used to optimize protein design efficiently.

People of Cradle
Headcount 10-50
Employee Profiles 17
Employee Profiles
People
Emanuele Monza
Customer Success Manager
People
Franziska Geiger
Machine Learning Engineer and employee #1
People
Daniel Danciu
CTO
People
Ena Škopelja
Software Engineer

Unlock access to complete

Funding Insights of Cradle

Cradle has successfully raised a total of $102.71M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $73 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series B — $73.0M
  • First Round

    (17 Nov 2022)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2024 Amount Series B - Cradle Valuation IVP
Nov, 2023 Amount Series A - Cradle Valuation Index Ventures
Nov, 2022 Amount Seed - Cradle Valuation Index Ventures , Kindred Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cradle

Cradle has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include IVP, Index Ventures and Kindred. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Growth in technology companies is supported through venture capital.
Founded Year Domain Location
Venture capital investments in technology startups and entrepreneurs.
Founded Year Domain Location
Venture capital funding is offered to pre-seed and seed startups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cradle

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cradle

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cradle Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cradle

Cradle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, EvolutionaryScale, Evozyne, Profluent Bio and Frontier Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
domain founded_year HQ Location
Provider of an AI models for protein design
domain founded_year HQ Location
Developer of proteins using protein engineering technology
domain founded_year HQ Location
An AI-based protein design platform is provided for drug discovery.
domain founded_year HQ Location
Bioinformatics platform is developed for drug discovery and chemoproteomics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cradle

Frequently Asked Questions about Cradle

When was Cradle founded?

Cradle was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Cradle located?

Cradle is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.

Who is the current CEO of Cradle?

Stef Van Grieken is the current CEO of Cradle. They have also founded this company.

Is Cradle a funded company?

Cradle is a funded company, having raised a total of $102.71M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.71M, raised on Nov 17, 2022.

What does Cradle do?

Cradle is engaged in developing AI-based software for protein engineering. Solutions are provided to biopharma and industrial bio sectors. The platform is designed to generate and optimize protein candidates, reducing experimental timelines. Applications are supported across therapeutics, agricultural solutions, and food ingredients. Data privacy and security are prioritized with bank-grade protection. Models are continuously improved through proprietary lab testing in Amsterdam.

Who are the top competitors of Cradle?

Cradle's top competitors include Nimbus Therapeutics, Profluent Bio and Eikon.

What products or services does Cradle offer?

Cradle offers Cradle AI Platform.

Who are Cradle's investors?

Cradle has 7 investors. Key investors include IVP, Index Ventures, Kindred, Chris Gibson, and Tom Glocer.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available